Back to ACAD
Cadent Capital Advisors, LLC → ACAD
Cadent Capital Advisors, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$4M
Q3 2026
Peak value
$6.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.8M |
| Q4 2025 | $6.3M |
| Q1 2026 | $6.3M |
| Q2 2026 | $6.6M |
| Q3 2026 | $4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4M | 23.0K | — | — |
| Q2 2026 | $6.6M | 37.9K | — | — |
| Q1 2026 | $6.3M | 38.5K | — | — |
| Q4 2025 | $6.3M | 34.9K | — | — |
| Q3 2025 | $5.8M | 32.8K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M